Skip to search formSkip to main contentSkip to account menu

tolmesoxide

Known as: 1,2-dimethoxy-4-methyl-5-(methylsulfinyl)benzene, 4,5-dimethoxy-o-tolyl methylsulfoxide 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Sulfoxides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The clinical pharmacology of tolmesoxide
SummaryThe haemodynamic response and pharmacokinetics of single dose oral tolmesoxide were studied at various dose levels in 4… 
1981
1981
Biotransformation of tolmesoxide in animals and man.
1. The excretion and metabolism of tolmesoxide ((4,5-dimethoxy-2-methylphenyl)-methylsulphoxide) has been studied in rat, dog and… 
1981
1981
Cardiovascular effects of intravenous tolmesoxide in hypertensive patients.
Tolmesoxide, a potent vasodilating compound, was infused intravenously (0.5 to 3.5 mg/kg b.w., rate of infusion: 2.5 to 10.0 mg… 
1980
1980
Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
Data, obtained by invasive hemodynamic monitoring, are now routinely available in our Intensive Care Unit, and are processed by… 
1980
1980
The clinical pharmacology of vasodilator antihypertensive drugs.
Vasodilator antihypertensive agents are defined and classified according to their mechanism and site of action. The effects of… 
1979
1979
The action of tolmesoxide on certain cardiovascular measurements in healthy human volunteers [proceedings].